Solid Biosciences Inc. (SLDB)

When we alerted readers to Solid Biosciences Inc. (SLDB) on December 17, 2025, it was trading at $5.84. The stock touched a 52-week high of $10.88 during intraday trading on Thursday (July 2, 2026), before closing at $10.

Price-action only: SLDB Corp (SLDB) movements set the tone for institutional models. Avoiding Lag: Real-Time Signals in (SLDB) Movement

The stock has a 50 day moving average of $7.62 and a two-hundred day moving average of $6.96. The firm has a market capitalization of $1.08 billion, a P/E ratio of -5.59 and a beta of 2.36. Solid Biosciences (NASDAQ:SLDB – Get Free Report) last announced its earnings results on Tuesday, May 12th.

Solid Biosciences is transitioning from a speculative Duchenne gene therapy play to a multi-asset rare disease platform. Find out why SLDB stock is a buy.

SLB N.V. is set to announce its second-quarter earnings soon, and Wall Street expects a double-digit decline in its profits.